Gregory C. Critchfield (Sera Prognostics Inc.)

Critchfield, Gregory C. (Sera Prognostics 201111– CEO before Board Chairman before Myriad Genetic Labs + BioTrove Inc)

	Organisation	Sera Prognostics Inc.
	Product	mass spectrometry solution/method

Record changed: 2011-12-04

More documents for Gregory C. Critchfield

[1] Bonislawski, Adam. (11/15/11). "News: Eyeing 2013 Launch of Mass Spec Preterm Birth Test, Sera Closes $19.3M Round, Names Critchfield CEO"....
[2] Sera Prognostics, Inc.. (11/15/11). "Press Release: Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor, Appoints Gregory C. Critchfield, MD as CEO". Salt Lake City, UT....
[3] Sera Prognostics, Inc.. (4/19/11). "Press Release: Sera Prognostics Appoints Two Industry Veterans to Lead the Commercialization of Its Preterm Birth Diagnostic Predictor"....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

Follow Us!

Top News

Upcoming Events

Associations

Partners

Gregory C. Critchfield (Sera Prognostics Inc.)

More documents for Gregory C. Critchfield